News | Artificial Intelligence | December 04, 2017

Fujifilm Introduces Artificial Intelligence Initiative for U.S. Market at RSNA 2017

Project will work to enhance Synapse portfolio of imaging informatics applications with AI technology

Fujifilm Introduces Artificial Intelligence Initiative for U.S. Market at RSNA 2017

December 4, 2017 — Fujifilm Medical Systems U.S.A. Inc. announced the expansion of the company's artificial intelligence (AI) development initiative with entry in the U.S. market. The AI development initiative will harness the power of AI to enhance Fujifilm’s imaging and informatics healthcare Synapse portfolio which includes Synapse PACS (picture archiving and communication system), Synapse Cardiovascular and Synapse VNA (vendor neutral archive), among other solutions. The initiative was on display at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1 in Chicago.

The program will be based in Raleigh, N.C., the global development headquarters for Fujifilm's Synapse portfolio, in collaboration with Fujifilm Corp.'s development team in Tokyo that will provide a wide range of image recognition technologies. Fujifilm will partner with its strategic customers in the U.S. market, to draw upon clinical insights and expertise in the field to bridge AI applications to imaging informatics solutions.

For more information: www.fujimed.com

Related Content

Artificial Intelligence in medical imaging was the top trend and buzz at RSNA 2018.

Artificial intelligence in medical imaging was the major buzz at RSNA 2018. The expo floor had a dedicated area just to highlight artificial intelligence software for medical imaging. More than 150 vendors on the expo floor were showing software using some level of AI or deep learning. 

Feature | Artificial Intelligence | January 17, 2019 | Dave Fornell, Editor
Artificial intelligence (AI) was by far the hottest trend discussed in sessions and across the expo floor at the worl
Artificial Intelligence Advances Threaten Privacy of Health Data
News | Artificial Intelligence | January 04, 2019
Advances in artificial intelligence (AI) have created new threats to the privacy of people's health data, a new...
Videos | Artificial Intelligence | December 12, 2018
This is a quick video tour of the Machine Learning Showcase at the ...
Bay Labs Collaborating With Edwards Lifesciences on AI for Heart Disease Detection
News | Artificial Intelligence | December 10, 2018
Medical artificial intelligence (AI) company Bay Labs announced a collaboration with Edwards Lifesciences focused on...
An example of artificial intelligence-aided clinical decision support software for a heart failure patient from the vendor HealthReveal. The AI pulled in relevant patient data from the electronic medical record and offers recommendations for care based on current American Heart Association (AHA) guidelines. It also offers the citations for where to find the guidelines and prescribing information for the recommended drug. Machine learning for cardiology.

An example of artificial intelligence-aided clinical decision support software for a heart failure patient from the vendor HealthReveal. The AI pulled in relevant patient data from the electronic medical record and offers recommendations for care based on current American Heart Association (AHA) guidelines. It also offers the citations for where to find the guidelines and prescribing information for the recommended drug.

Feature | Artificial Intelligence | December 06, 2018 | Lonny Reisman, M.D.
The consistent provision of guideline-directed medical therapy (GDMT) — care delivered according to established guide
AI Predicts Cardiovascular Disease Risk From CT Scans
News | Artificial Intelligence | November 27, 2018
November 27, 2018 – Zebra Medical Vision and Clalit Health Services announced the completion of a research project th
AI Algorithm Outperforms Most Cardiologists in Heart Murmur Detection
News | Artificial Intelligence | November 11, 2018
At the American Heart Association’s (AHA) Scientific Sessions 2018, Nov. 10-12 in Chicago, Eko presented a clinical...
Overlay Init